Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
GPC Biotech AG (GPCB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: GPCB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
GPC Biotech At A Glance
Andrew Vaino
•
Jul 30
•
Comment!
Biotech Day in Review: Eisai Buys Morphotek for $325 Million
Centient Biotech Investor
•
Mar 23
•
Comment!
Biotech in Review: Genentech Extends Uses for Avastin and Xeloda
Centient Biotech Investor
•
Feb 25
•
1 Comment
Biotech Stock Review: GPC Biotech Completes New Drug Approval
Centient Biotech Investor
•
Feb 20
•
Comment!
Biotech Week in Review: Onyx Is Star of the Week
Centient Biotech Investor
•
Feb 19
•
Comment!
Biotech Rises To New Record High
Centient Biotech Investor
•
Jan 22
•
Comment!
More articles on GPCB »
Sentiment
What advice would you give to
GPCB?
123 characters left
What's your view of GPCB?
Make sure you include GPCB
140 characters left
|
Settings